1. Home
  2. SBFM vs JAGX Comparison

SBFM vs JAGX Comparison

Compare SBFM & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunshine Biopharma Inc.

SBFM

Sunshine Biopharma Inc.

N/A

Current Price

$1.15

Market Cap

4.3M

Sector

Health Care

ML Signal

N/A

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

N/A

Current Price

$0.34

Market Cap

4.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SBFM
JAGX
Founded
2006
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
4.9M
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
SBFM
JAGX
Price
$1.15
$0.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$7.00
$60.00
AVG Volume (30 Days)
393.8K
226.9K
Earning Date
04-03-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
82.42
EPS
N/A
N/A
Revenue
$36,305,891.00
$11,511,000.00
Revenue This Year
$40.47
$61.58
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.11
N/A
52 Week Low
$0.25
$0.22
52 Week High
$3.05
$8.00

Technical Indicators

Market Signals
Indicator
SBFM
JAGX
Relative Strength Index (RSI) 40.08 17.64
Support Level $1.09 $0.29
Resistance Level $1.29 $0.46
Average True Range (ATR) 0.09 0.10
MACD 0.02 -0.01
Stochastic Oscillator 40.07 3.48

Price Performance

Historical Comparison
SBFM
JAGX

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

Share on Social Networks: